Example: Heart Attack

Search clinical trials for: Deoxycholic Acid

Total 50 results

NCT04502381

Recruiting

Combined Inhalational With Intravenous Amphotericin B Versus Intravenous Amphotericin B Alone for Pulmonary Mucormycosis

Conditions: Pulmonary Mucormycosis
NCT04089722

Recruiting

Efficacy and Safety of Deoxycholic Acid Injections for Removal of Adipose Tissue in the "Bra Strap Fat" Region

Conditions: Brassiere Strap Fat (BSF); Bra Strap Fat (BSF)
NCT04072640

Not yet recruiting

Three Induction Treatments on Cryptococcal Meningitis

Conditions: Cryptococcal Meningitis; HIV/AIDS
NCT04054011

Recruiting

Safety and Efficacy of Deoxycholic Acid Injection for Reduction of Upper Inner Thigh Fat

Conditions: Adiposity
NCT03691415

Recruiting

Evaluation of the Safety and Effectiveness of BELKYRA® Inj. for the Treatment of Patients With Submental Fullness Due to Submental Fat: A Postmarketing Surveillance Study in Korea

Conditions: Submental Fullness
NCT03682471

Completed

Long-term 24-month Follow-up Study on Safety and Maintenance of Efficacy of ATX-101 (Sodium Deoxycholate Injection)

Conditions: Subcutaneous Fat
NCT03510598

Active, not recruiting

Submental Study (Sequential Treatment Approach)

Conditions: Body Fat Disorder
NCT03361176

Completed

Kybella With Triamcinolone

Conditions: Adiposity
NCT03284034

Active, not recruiting

Cryolipolysis Versus ATX-101 (Deoxycholic Acid) for Upper Back Fat

Conditions: Upper Back Fat
NCT03241563

Completed

Subcutaneous Sodium Deoxycholate Injections With or Without Triamcinolone for Reduction of Submental Fat

Conditions: Fat Reduction
NCT02979210

Completed

Infant Fecal Insult Study

Conditions: Dermatitis
NCT02438813

Completed

Condition of Submental Fullness and Treatment Outcomes Registry

Conditions: Submental Fullness
NCT02283905

Recruiting

Amphotericin-B and Voriconazole for Pulmonary Blastomycosis

Conditions: Blastomycosis
NCT02163902

Completed

Long-term Follow-up Study on Safety and Maintenance of Efficacy of ATX-101

Conditions: Submental Fat; Healthy
NCT02159729

Completed

Long Term Follow-up Study on Safety and Maintenance of Efficacy of ATX-101

Conditions: Submental Fat; Healthy
NCT02136030

Unknown status

Liposomal Amphotericin B for the Treatment of Cryptococcal Meningitis

Conditions: Cryptococcal Meningitis
NCT02123134

Completed

Safety Study of Deoxycholic Acid for the Reduction of Localized Subcutaneous Fat in the Submental Area in Subjects 65 to 75 Years of Age

Conditions: Moderate to Severe Convexity of Submental Fat; Safety; Efficacy
NCT02035267

Completed

Safety Study of ATX-101 (Deoxycholic Acid) in Subjects With Mild or Extreme Fullness of Submental Fat

Conditions: Moderate to Severe Convexity of Submental Fat; Safety; Efficacy
NCT02007434

Completed

Patient Experience Study of Deoxycholic Acid Injection

Conditions: Moderate or Severe Submental Fullness
NCT01945281

Terminated

Safety, Tolerability, and Efficacy of Caspofungin Versus Amphotericin B Deoxycholate in the Treatment of Invasive Candidiasis in Neonates and Infants (MK-0991-064)

Conditions: Candidiasis, Invasive
NCT01857479

Completed

A Randomized Controlled Trial of Inhaled Amphotericin B for Maintaining Remission in Allergic Bronchopulmonary Aspergillosis

Conditions: Allergic Bronchopulmonary Aspergillosis
NCT01632917

Completed

Open-Label Pharmacokinetic Study of Final Formulations of ATX-101

Conditions: Healthy
NCT01546142

Completed

Phase 3 Study of Deoxycholic Acid Injection (ATX-101) Versus Placebo for the Reduction of Localized Subcutaneous Fat in the Submental Area

Conditions: Moderate or Severe Submental Fullness
NCT01542034

Completed

Phase 3 Study of Deoxycholic Acid Injection (ATX-101) Versus Placebo for the Reduction of Localized Subcutaneous Fat in the Submental Area

Conditions: Moderate or Severe Submental Fullness
NCT01462786

Completed

To Evaluate the Safety, Tolerability and to Compare the Pharmacokinetic Profile of ATX-101

Conditions: Healthy
NCT01426373

Completed

Open-Label Study of Deoxycholic Acid for the Reduction of Localized Subcutaneous Fat in the Submental Area

Conditions: Moderate or Severe Submental Fullness
NCT01319916

Completed

Lipid and Adipokine Profiles Following Subcutaneous Injection of ATX-101 Into Abdominal Fat Tissue

Conditions: Healthy
NCT01320761

Completed

A Study to Assess Injection Comfort of Two Formulations of ATX-101

Conditions: Healthy
NCT01310738

Terminated

Efficacy and Safety Study of Drugs for Treatment of Visceral Leishmaniasis in Brazil

Conditions: Visceral Leishmaniasis
NCT01305577

Completed

Evaluation of Safety and Efficacy of Deoxycholic Acid Injection (ATX-101) in the Reduction of Submental Fat

Conditions: Moderate or Severe Submental Fullness
NCT01294644

Completed

Evaluation of Safety and Efficacy of Deoxycholic Acid Injection (ATX-101) in the Reduction of Submental Fat

Conditions: Moderate or Severe Submental Fullness
NCT01032889

Completed

Deoxycholic Acid Injection Submental Fat (SMF) Magnetic Resonance Imaging (MRI) and Subject-reported Outcome Measures Study

Conditions: Moderate or Severe Submental Fullness
NCT01032187

Completed

Amphotericin B to Treat Visceral Leishmaniasis in Brazilian Children

Conditions: Visceral Leishmaniasis
NCT00885703

Completed

High-Dose Fluconazole for the Treatment of Cryptococcal Meningitis in HIV-Infected Individuals

Conditions: Cryptococcal Meningitis; HIV Infections
NCT00851747

Terminated

A Study of the Efficacy of Subcutaneous Phosphatidylcholine and Deoxycholate Injections for Localized Fat Removal

Conditions: Obesity
NCT00835952

Completed

ATX-101 Abdominoplasty

Conditions: Characteristics of Subcutaneous Fat
NCT00815516

Terminated

Study to Compare the Efficacy and Safety of Micafungin Versus Conventional Amphotericin B for the Treatment of Neonatal Candidiasis

Conditions: Candidiasis
NCT00757081

Completed

Study to Evaluate the Effect of Injection Lypolysis (Lipodissolve) Treatments to Reduce Body Fat

Conditions: Abdominal Subcutaneous Fat
NCT00696969

Completed

Safety and Efficacy Study to Evaluate Different Combination Treatment Regimens for Visceral Leishmaniasis

Conditions: Visceral Leishmaniasis
NCT00628719

Completed

Single Infusion of Liposomal Amphotericin B in Indian Visceral Leishmaniasis

Conditions: Visceral Leishmaniasis
NCT00618618

Completed

Phase 2 Study of Deoxycholic Acid Injection (ATX-101) for the Reduction of Submental Fat

Conditions: Moderate or Severe Submental Fullness
NCT00618709

Completed

Dose-Escalation Safety and Pharmacokinetic Study of ATX-101

Conditions: Healthy
NCT00618722

Completed

Phase 1-2 Study of Deoxycholic Acid Injection (ATX-101) for the Reduction of Submental Fat

Conditions: Moderate or Severe Submental Fullness
NCT00608842

Completed

Phase 2 Study for the Treatment of Superficial Lipomas

Conditions: Lipoma
NCT00523965

Completed

Combination Therapy in Indian Visceral Leishmaniasis

Conditions: Leishmaniasis, Visceral
NCT00422188

Completed

Deoxycholic Acid Injection for the Treatment of Superficial Lipomas

Conditions: Lipoma
NCT00361517

Completed

To Determine Whether Galactomannan Test Will Help to Detect Fungal Infections Early and Hence Start Treatment Early

Conditions: Aspergillosis
NCT00310505

Completed

Amphotericin B Treatment in Visceral Leishmaniasis

Conditions: Visceral Leishmaniasis
NCT00002742

Completed

Antifungal Therapy for Fever and Neutropenia in Patients Receiving Treatment for Hematologic Cancer

Conditions: Chronic Myeloproliferative Disorders; Infection; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes
NCT00003031

Completed

Comparison of Voriconazole and Amphotericin B in Treating Patients With Aspergillosis

Conditions: Infection; Pulmonary Complications